Bank Of America Corp Xenon Pharmaceuticals Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Bank Of America Corp holds 142,332 shares of XENE stock, worth $6.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

142,332

Previous 157,104 9.4%

Holding current value

$6.4 Million

Previous $6.76 Million 17.95%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$36.25 - $43.75 $535,485 - $646,275	-14,772 Reduced 9.4%	142,332 $5.55 Million
Q1 2024 May 15, 2024	BUY	$42.66 - $50.04 $1.01 Million - $1.19 Million	23,692 Added 17.76%	157,104 $6.76 Million
Q4 2023 Feb 14, 2024	SELL	$28.7 - $46.46 $745,166 - $1.21 Million	-25,964 Reduced 16.29%	133,412 $6.14 Million
Q2 2023 Aug 14, 2023	BUY	$34.84 - $43.54 $880,232 - $1.1 Million	25,265 Added 18.84%	159,376 $6.14 Million
Q1 2023 May 12, 2023	BUY	$33.46 - $40.35 $1.52 Million - $1.83 Million	45,363 Added 51.11%	134,111 $4.8 Million
Q4 2022 Feb 10, 2023	BUY	$33.06 - $39.43 $2.04 Million - $2.43 Million	61,753 Added 228.76%	88,748 $3.5 Million
Q3 2022 Nov 14, 2022	SELL	$30.79 - $39.82 $297,431 - $384,661	-9,660 Reduced 26.35%	26,995 $974,000
Q2 2022 Aug 12, 2022	BUY	$25.44 - $35.16 $772,765 - $1.07 Million	30,376 Added 483.77%	36,655 $1.12 Million
Q1 2022 May 16, 2022	SELL	$25.09 - $33.13 $916,261 - $1.21 Million	-36,519 Reduced 85.33%	6,279 $192,000
Q4 2021 Feb 08, 2022	BUY	$15.6 - $35.4 $443,211 - $1.01 Million	28,411 Added 197.48%	42,798 $1.34 Million
Q3 2021 Nov 15, 2021	BUY	$14.86 - $19.45 $110,082 - $144,085	7,408 Added 106.15%	14,387 $220,000
Q2 2021 Sep 13, 2021	BUY	$16.81 - $20.0 $117,316 - $139,580	6,979 New	6,979 $130,000

Others Institutions Holding XENE

# of Institutions

221

Shares Held

70.6M

Call Options Held

59.7K

Put Options Held

60.7K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.8B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Xenon Pharmaceuticals Inc. Transaction History